In January 2021, Brook Jackson sued Pfizer and two companies the Big Pharma giant contracted with to work on the COVID-19 jab trials: Ventavia Research Group and ICON PLC.
A whistleblower lawsuit alleging fraud during Pfizer’s COVID vaccine trials is moving forward, after a district court judge unsealed the complaint, including 400 pages of exhibits.https://t.co/qgNImhN5Ov
— Robert F. Kennedy Jr (@RobertKennedyJr) March 2, 2022
Jackson was a former employee of Ventavia in 2020 before the company fired her for making a complaint to the U.S. Food and Drug Administration (FDA) over alleged misconduct during the trials.
She gave The BMJ a series of internal documents, photos, and recordings that highlighted the alleged misconduct by Ventavia.
As reported by The Defender:
Jackson filed the complaint in the U.S. District Court, Eastern District of Texas, Beaumont Division, under the False Claims Act. The lawsuit includes several charges of fraud and retaliation on the part of both Ventavia and Pfizer.
The complaint remained under seal until Feb. 10, when U.S. District Court Judge Michael Truncale ordered it unsealed.
Pfizer ‘deliberately withheld crucial information’ about vaccine’s safety
According to Jackson’s lawsuit, Pfizer, Ventavia and ICON “deliberately withheld crucial information from the United States that calls the safety and efficacy of their vaccine into question.”
The lawsuit states:
“Defendants concealed violations of both their clinical trial protocol and federal regulations, including falsification of clinical trial documents.
“Due to [the] Defendants’ scheme, millions of Americans have received a misbranded vaccination which is potentially not as effective as represented.”
The core allegations of Jackson’s lawsuit include claims against Ventavia and Pfizer of:
- Making or using false records or statements to cause claims to be paid.
- Presentation of false and/or fraudulent claims.
- Making or using false records or statements material to false and/or fraudulent claims.
For instance, Jackson alleges:
“From 2020 to the present, Defendants [Ventavia and Pfizer] knowingly made, used, or caused to be made or used, false records or statements that were material to false and/or fraudulent claims paid or approved by the United States [Department of Defense, or DoD]. These false records or statements include the clinical trial protocol Pfizer submitted to the United States and the falsified source documents and data behind Defendants’ trial results and EUA application.
“By creating and carrying out their fraudulent schemes, Defendants knowingly and repeatedly violated … the False Claims Act. Defendants’ false records were material to Pfizer’s claims for payment for the vaccine at issue. The United States DoD would not have paid Pfizer if it knew that the clinical trial protocol was not complied with by Defendants, because the protocol violations call the integrity and validity of both the entire clinical trial and Pfizer’s EUA into question.
“Defendants’ false records also went to the very essence of the bargain the United States contracted for. DoD contracted to purchase vaccines found effective by a valid clinical trial conducted according to the protocol submitted by Pfizer. The integrity of the entire clinical trial was compromised by the trial protocol violations, false source documents, and the false data that resulted, which calls the vaccine’s EUA into question. Had the United States DoD known of Defendants’ false records, it would not have paid Pfizer.
“Defendants’ use, or causation of use, of material false records was a foreseeable factor in the United States DoD’s loss and a consequence of Defendants’ schemes. By virtue of Defendants’ actions, the United States DoD has suffered actual damages and is entitled to recover treble damages plus a civil monetary penalty for each false and/or fraudulent claim.”
The documents for Jackson’s lawsuit were released after U.S. Department of Justice (DOJ) attorneys declined to intervene on her behalf in the case.
DOJ to sit out whistleblower lawsuit accusing Pfizer of ‘cutting corners’ in COVID vaccine trial | Just The News https://t.co/mp40tZBmqk
— John Solomon (@jsolomonReports) February 24, 2022
Just the News explained:
The U.S. government is not getting directly involved in a whistleblower lawsuit alleging that Pfizer’s COVID-19 vaccine clinical trials included fraud, though it might try to dismiss the lawsuit later.
The Justice Department, representing the FDA, filed a “notice of election to decline intervention” last month, more than a year after the suit was filed, but asked a federal judge to first get “written consent” from the feds if the parties want to dismiss or settle the case.
The government reserves the right to intervene at a later date in the False Claims Act lawsuit, which seeks to recover damages on its behalf and for the whistleblower, Brook Jackson.
Jackson accuses Pfizer and two contractors of “cutting corners in clinical trials” and falsifying clinical trial documents in their “race to secure billions in federal funding and become the first to market.” The result, she claims, was millions of Americans receiving “a misbranded vaccination which is potentially not as effective as represented.”
With the latest batch of Pfizer documents released on March 1st, could that strengthen Jackson’s accusations of Pfizer “cutting corners in clinical trials.”